Monte Rosa Therapeutics Inc
GLUEHealthcare|Biotechnology|USA
$23.02
-1.48 (-6.04%)
Tangible Book
$6.19
Clinical Trials (3)
| Trial | Conditions | Phase | Status | Enrollment | Design | Drug |
|---|---|---|---|---|---|---|
| NCT05546268 Study of Oral MRT-2359 in Selected Cancer Patients | NSCLC, SCLC | P1P2 | Active | 174 | Open-label | Oral MRT-2359, Oral MRT-2359, Oral MRT-2359, Oral MRT-2359, Oral MRT-2359, Oral MRT-2359 |
| NCT07119125 A First-in-human, 3-part Study of MRT-8102 in Healthy Participants and Participants at Cardiovascular Risk With Elevated CRP | Healthy Volunteers, Elevated CRP | P1 | Active | 100 | RCT, Double-blind | MRT-8102, Placebo |
| NCT06597799 First-in-human Study of MRT-6160 in Healthy Subjects | Healthy Volunteers | P1 | Completed | 108 | RCT, Double-blind | MRT-6160, Placebo |